Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)

NCT00926055 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DRUG: Ezetrol (Ezetimibe)
DRUG: Vytorin (Ezetimibe + Simvastatin)

Sponsor

Korea University